Issue 002 | U.S. Pilot | US

GLMD

Galmed Pharmaceuticals Ltd.

Screen state: Passing Source state: Verified 20-F | 2026-03-31 Filing currency: USD
Internal NCAV Discount 77.2%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
18,627,000USD
Total Liabilities
2,845,000USD
NCAV
15,782,000USD
Cash
3,985,000USD
NCAV per share
2.40USD/share
Evidence
10 annual | 21 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible in the details.

business_profile_v1

Business profile: 0 of 12 fields established by the current extractor.

Business Profile Field Details

Business Description

Missing Source

Not established by the current extractor from the selected filing context.

Revenue Model

Missing Source

Not established by the current extractor from the selected filing context.

Customers And Channels

Missing Source

Not established by the current extractor from the selected filing context.

Segments And Geography

Missing Source

Not established by the current extractor from the selected filing context.

Tangible Operations Assets

Missing Source

Not established by the current extractor from the selected filing context.

Value Chain

Missing Source

Not established by the current extractor from the selected filing context.

Competition Positioning

Missing Source

Not established by the current extractor from the selected filing context.

Business Lifecycle Cyclicality

Missing Source

Not established by the current extractor from the selected filing context.

Strategy And Capital Allocation

Missing Source

Not established by the current extractor from the selected filing context.

Management Governance Signals

Missing Source

Not established by the current extractor from the selected filing context.

Disclosed Risks

Missing Source

Not established by the current extractor from the selected filing context.

Known Unknowns

Missing Source

Not established by the current extractor from the selected filing context.

Business Profile Sources
Source Filing Date Type Status Provenance
S1 0001493152-26-014182 2026-03-31 20-F Verified Data Vault | sec/cleaned/cik=0001595353/accession=0001493152-26-014182/parser=html-cleaner-v1/full.txt
Share Count & Per-Share Comparability

Data Vault has not published the normalized share-count artifact for this company.

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
20-F
USD
2024-12-31
20-F
USD
2023-12-31
20-F
USD
2022-12-31
20-F
USD
2021-12-31
20-F
USD
2020-12-31
20-F
USD
2019-12-31
20-F
USD
2018-12-31
20-F
USD
2017-12-31
20-F
USD
2016-12-31
20-F
USD
Revenue n/a n/a n/a n/a n/a 0 0 2,038,000 1,085,000 467,000
Operating Income n/a n/a n/a n/a n/a -30,210,000 -22,376,000 -10,715,000 -12,364,000 n/a
Net Income -10,309,000 -7,517,000 -6,912,000 -17,866,000 -32,467,000 -28,771,000 -20,461,000 -9,856,000 -12,299,000 -16,953,000
Cash From Operations -6,315,000 -5,880,000 -6,137,000 -18,501,000 -32,892,000 -26,287,000 -14,937,000 -9,023,000 -12,067,000 -12,129,000
Capex n/a n/a n/a -4,000 -11,000 -44,000 -12,000 -90,000 -12,000 -17,000
Free Cash Flow n/a n/a n/a -18,505,000 -32,903,000 -26,331,000 -14,949,000 -9,113,000 -12,079,000 -12,146,000
Cash And Equivalents 3,985,000 4,652,000 2,861,000 2,016,000 2,884,000 6,947,000 15,931,000 24,159,000 13,021,000 3,097,000
Accounts Receivable n/a 672,000 480,000 825,000 1,125,000 812,000 827,000 218,000 155,000 284,000
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets 18,627,000 16,124,000 13,239,000 14,724,000 36,054,000 51,811,000 76,430,000 90,406,000 19,152,000 15,732,000
Total Assets 18,627,000 18,500,000 16,629,000 16,561,000 36,605,000 52,381,000 77,139,000 90,600,000 19,643,000 16,450,000
Total Current Liabilities 2,845,000 2,173,000 2,750,000 3,094,000 5,879,000 8,012,000 6,934,000 2,706,000 3,848,000 4,579,000
Total Liabilities 2,845,000 2,173,000 2,750,000 3,138,000 6,108,000 8,228,000 7,286,000 2,706,000 3,848,000 5,375,000
Shareholders Equity 15,782,000 16,327,000 13,879,000 13,423,000 30,497,000 44,153,000 69,853,000 87,894,000 15,795,000 11,075,000
Shares Outstanding 6,581,390 1,654,428 5,045,324 25,203,396 25,088,414 21,325,975 21,139,385 21,018,919 14,435,161 12,149,226
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 4,311,323 930,822 2,769,539 1,676,183 1,639,843 21,280,787 21,114,399 18,137,689 12,487,349 11,374,653
Weighted Avg Shares Basic 4,311,323 930,822 2,769,539 1,676,183 1,639,843 21,280,787 21,114,399 18,137,689 12,487,349 11,374,653
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2025-12-31
20-F
USD
2025-12-31
20-F
USD
2025-09-30
6-K
USD
2025-06-30
6-K
USD
2025-03-31
6-K
USD
2024-12-31
6-K
USD
2024-09-30
6-K
USD
2024-06-30
6-K
USD
2024-03-31
6-K
USD
2023-12-31
6-K
USD
2023-06-30
6-K
USD
2023-03-31
6-K
USD
2022-12-31
6-K
USD
2022-06-30
6-K
USD
2022-03-31
6-K
USD
2021-12-31
6-K
USD
2021-06-30
6-K
USD
2021-03-31
6-K
USD
2020-12-31
6-K
USD
2020-06-30
6-K
USD
2020-03-31
6-K
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0 n/a n/a
Operating Income n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -30,210,000 -12,278,000 n/a
Net Income -115,000 -115,000 -5,491,000 -3,599,000 -1,104,000 -7,517,000 -4,308,000 -2,394,000 -1,275,000 -6,912,000 -3,423,000 -1,830,000 -17,866,000 -9,877,000 -6,143,000 -32,467,000 -17,301,000 -8,905,000 -28,771,000 -11,589,000 -6,063,000
Cash From Operations n/a n/a -4,370,000 -2,435,000 n/a -5,880,000 -3,972,000 -2,847,000 n/a -6,137,000 -3,062,000 n/a -18,501,000 -11,363,000 n/a -32,892,000 -16,917,000 n/a -26,287,000 -12,842,000 n/a
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4,000 -3,000 n/a -11,000 -8,000 n/a -44,000 -5,000 n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -18,505,000 -11,366,000 n/a -32,903,000 -16,925,000 n/a -26,331,000 -12,847,000 n/a
Cash And Equivalents 3,985,000 3,985,000 3,314,000 4,964,000 n/a 4,652,000 n/a 1,837,000 n/a 2,861,000 1,009,000 n/a 2,016,000 1,980,000 n/a 2,884,000 7,923,000 n/a 6,947,000 5,553,000 n/a
Total Current Assets 18,627,000 18,627,000 19,724,000 21,084,000 n/a 16,124,000 n/a 10,076,000 n/a 13,239,000 9,786,000 n/a 14,724,000 23,130,000 n/a 36,054,000 51,665,000 n/a 51,811,000 64,211,000 n/a
Total Liabilities n/a 2,845,000 2,472,000 n/a n/a 2,173,000 n/a n/a n/a 2,750,000 n/a n/a 3,138,000 2,863,000 n/a 6,108,000 7,326,000 n/a 8,228,000 4,965,000 n/a
Shares Outstanding 6,581,390 6,581,390 5,479,231 5,303,050 n/a 1,664,884 n/a 6,358,747 n/a 5,045,324 n/a n/a 1,680,232 25,088,414 n/a 25,088,414 25,083,914 n/a 21,325,975 21,153,166 n/a
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 4,311,323 4,311,323 5,460,476 3,948,190 n/a 930,822 829,500 6,294,748 n/a 2,769,539 1,680,232 n/a 1,676,183 1,672,561 n/a 1,639,843 25,083,914 n/a 21,280,787 21,153,166 n/a
Weighted Avg Shares Basic 4,311,323 4,311,323 5,460,476 3,948,190 n/a 930,822 829,500 6,294,748 n/a 2,769,539 1,680,232 n/a 1,676,183 1,672,561 n/a 1,639,843 25,083,914 n/a 21,280,787 21,153,166 n/a
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 18,627,000USD derived 2025-12-31 1.00 n/a
Total Liabilities 2,845,000USD derived 2025-12-31 1.00 n/a
Cash 3,985,000USD derived 2025-12-31 1.00 n/a
Shares Outstanding 6,581,390 derived 2025-12-31 1.00 n/a
NCAV 15,782,000USD derived 2025-12-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.40USD derived 2025-12-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 77.2% derived 2025-12-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001595353
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001595353/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001595353/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
18
Imported At
2026-08-15T12:52:04+00:00
Rendered At
2026-08-16T03:29:43+00:00

Run Audit

Mary Run
f75c5d221f074da8a489fba328e8ef51
Mary As Of
2026-07-18
Accession
0001493152-26-014182
CIK
0001595353
Mary Filing Date
2026-03-31
Filing Currency
USD
Internal Discount
77.2%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=f75c5d221f074da8a489fba328e8ef51; mary_as_of=2026-07-18; mary_filing_date=2026-03-31; mary_accession=0001493152-26-014182; mary_cik=0001595353; gnni_supporting_filing_date=2026-03-31; internal_discount=0.772308; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive